| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.33 | 3e-17 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-14 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-13 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.31 | 7e-10 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.29 | 4e-09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-08 |